Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"Appropriate" label warnings, improved postmarketing surveillance urged.

This article was originally published in The Tan Sheet

Executive Summary

DIETARY SUPPLEMENT SAFETY: "APPROPRIATE" LABEL WARNINGS URGED by the Presidential Commission on Dietary Supplement Labels in a draft report released June 24. The commission was created under the provisions of the Dietary Supplement Health & Education Act to address issues concerning the labeling of dietary supplements. Although safety issues are not specifically included in the group's charge, the commission discusses them because of concerns expressed in public submissions, the draft report states.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087232

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel